These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Identification of transcriptome characteristics of granulosa cells and the possible role of UBE2C in the pathogenesis of premature ovarian insufficiency. Liu D; Guan X; Liu W; Jia Y; Zhou H; Xi C; Zhao M; Fang Y; Wu L; Li K J Ovarian Res; 2023 Oct; 16(1):203. PubMed ID: 37848988 [TBL] [Abstract][Full Text] [Related]
43. Prevalence and clinical associations with premature ovarian insufficiency, early menopause, and low ovarian reserve in systemic sclerosis. Jutiviboonsuk A; Salang L; Eamudomkarn N; Mahakkanukrauh A; Suwannaroj S; Foocharoen C Clin Rheumatol; 2021 Jun; 40(6):2267-2275. PubMed ID: 33244723 [TBL] [Abstract][Full Text] [Related]
44. The effect of 12-month dehydroepiandrosterone supplementation on the menstrual pattern, ovarian reserve markers, and safety profile in women with premature ovarian insufficiency. Wong QHY; Yeung TWY; Yung SSF; Ko JKY; Li HWR; Ng EHY J Assist Reprod Genet; 2018 May; 35(5):857-862. PubMed ID: 29520734 [TBL] [Abstract][Full Text] [Related]
46. Primary ovarian insufficiency, meiosis and DNA repair. Veitia RA Biomed J; 2020 Apr; 43(2):115-123. PubMed ID: 32381463 [TBL] [Abstract][Full Text] [Related]
47. Premature ovarian insufficiency - the need for a genomic map. Cloke B; Rymer J Climacteric; 2021 Oct; 24(5):444-452. PubMed ID: 34308731 [TBL] [Abstract][Full Text] [Related]
48. ZSWIM7 Is Associated With Human Female Meiosis and Familial Primary Ovarian Insufficiency. McGlacken-Byrne SM; Le Quesne Stabej P; Del Valle I; Ocaka L; Gagunashvili A; Crespo B; Moreno N; James C; Bacchelli C; Dattani MT; Williams HJ; Kelberman D; Achermann JC; Conway GS J Clin Endocrinol Metab; 2022 Jan; 107(1):e254-e263. PubMed ID: 34402903 [TBL] [Abstract][Full Text] [Related]
49. [NR5A1 and ovarian failure]. Bashamboo A; Ravel C; Brauner R; McElreavey K Med Sci (Paris); 2009 Oct; 25(10):809-13. PubMed ID: 19849982 [TBL] [Abstract][Full Text] [Related]
50. Novel variants in women with premature ovarian function decline identified via whole-exome sequencing. Tang R; Yu Q J Assist Reprod Genet; 2020 Oct; 37(10):2487-2502. PubMed ID: 32789750 [TBL] [Abstract][Full Text] [Related]
51. Primary Ovarian Insufficiency in Women With Addison's Disease. Vogt EC; Breivik L; Røyrvik EC; Grytaas M; Husebye ES; Øksnes M J Clin Endocrinol Metab; 2021 Jun; 106(7):e2656-e2663. PubMed ID: 33686417 [TBL] [Abstract][Full Text] [Related]
52. Uses of anti-Müllerian hormone (AMH) measurement before and after cancer treatment in women. Dunlop CE; Anderson RA Maturitas; 2015 Mar; 80(3):245-50. PubMed ID: 25596814 [TBL] [Abstract][Full Text] [Related]
53. Pathogenic variants of meiotic double strand break (DSB) formation genes PRDM9 and ANKRD31 in premature ovarian insufficiency. Wang Y; Guo T; Ke H; Zhang Q; Li S; Luo W; Qin Y Genet Med; 2021 Dec; 23(12):2309-2315. PubMed ID: 34257419 [TBL] [Abstract][Full Text] [Related]
54. The probability and possible influence factors of intermittent ovarian function recovery in patients with premature ovarian insufficiency. Du J; Wang X; Wei M; Huang Q; Bi Y; Huang W; Yuan L; Yang Y Reprod Biomed Online; 2022 Dec; 45(6):1275-1283. PubMed ID: 36151013 [TBL] [Abstract][Full Text] [Related]
55. Genetics of Menopause and Primary Ovarian Insufficiency: Time for a Paradigm Shift? Laven JSE Semin Reprod Med; 2020 Sep; 38(4-05):256-262. PubMed ID: 33648006 [TBL] [Abstract][Full Text] [Related]
56. Low Anti-Müllerian Hormone in Pediatric Cancer Survivors in the Early Years after Gonadotoxic Therapy. Elchuri SV; Patterson BC; Brown M; Bedient C; Record E; Wasilewski-Masker K; Mertens AC; Meacham LR J Pediatr Adolesc Gynecol; 2016 Aug; 29(4):393-9. PubMed ID: 26924632 [TBL] [Abstract][Full Text] [Related]
57. Current concepts in premature ovarian insufficiency. Maclaran K; Panay N Womens Health (Lond); 2015 Mar; 11(2):169-82. PubMed ID: 25776291 [TBL] [Abstract][Full Text] [Related]
58. Association of skewed X-chromosome inactivation with FMR1 CGG repeat length and anti-Mullerian hormone levels: a cohort study. Barad DH; Darmon S; Weghofer A; Latham GJ; Filipovic-Sadic ; Wang Q; Kushnir VA; Albertini DF; Gleicher N Reprod Biol Endocrinol; 2017 Apr; 15(1):34. PubMed ID: 28454580 [TBL] [Abstract][Full Text] [Related]
59. Progressive decline of residual follicle pool after clinical diagnosis of autoimmune ovarian insufficiency. Falorni A; Brozzetti A; Aglietti MC; Esposito R; Minarelli V; Morelli S; Sbroma Tomaro E; Marzotti S Clin Endocrinol (Oxf); 2012 Sep; 77(3):453-8. PubMed ID: 22417127 [TBL] [Abstract][Full Text] [Related]
60. Huyang yangkun formula protects against 4-Vinylcyclohexene diepoxide-induced premature ovarian insufficiency in rats via the Hippo-JAK2/STAT3 signaling pathway. Xie L; Wu S; Cao D; Li M; Liu J; Nie G; Li Y; Yang H Biomed Pharmacother; 2019 Aug; 116():109008. PubMed ID: 31152926 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]